Ethicon Acquires Rights of Takeda’s TachoSil Fibrin Sealant Patch for ~$400M


  • Takeda tosells its TachoSil Fibrin Sealant Patch along with its ~80 employees to Ethicon for ~ 400M. The transaction is expected to close in H2’19
  • Ethicon to acquire the assets and licenses that support the manufacturing, licensing and commercialization of TachoSil while Takeda will retain rights to TachoSil products and supply it to Ethicon
  • TachoSil, Fibrin Sealant Patch is a surgical patch designed to control bleeding and generated a revenue of $155M in 2018

Click here to read full press release/ article | Ref: Takeda | Image: Insider